Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.

BACKGROUND:Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the a...

Full description

Bibliographic Details
Main Authors: Kazuhito Mietani, Masahiko Sumitani, Toru Ogata, Nobutake Shimojo, Reo Inoue, Hiroaki Abe, Gaku Kawamura, Yoshitsugu Yamada
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0222721
id doaj-523fab77c39043aa807406a2cefaf125
record_format Article
spelling doaj-523fab77c39043aa807406a2cefaf1252021-03-03T21:07:06ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011410e022272110.1371/journal.pone.0222721Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.Kazuhito MietaniMasahiko SumitaniToru OgataNobutake ShimojoReo InoueHiroaki AbeGaku KawamuraYoshitsugu YamadaBACKGROUND:Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. METHODS:Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. RESULTS:Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). CONCLUSIONS:Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium- related CNS damage.https://doi.org/10.1371/journal.pone.0222721
collection DOAJ
language English
format Article
sources DOAJ
author Kazuhito Mietani
Masahiko Sumitani
Toru Ogata
Nobutake Shimojo
Reo Inoue
Hiroaki Abe
Gaku Kawamura
Yoshitsugu Yamada
spellingShingle Kazuhito Mietani
Masahiko Sumitani
Toru Ogata
Nobutake Shimojo
Reo Inoue
Hiroaki Abe
Gaku Kawamura
Yoshitsugu Yamada
Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
PLoS ONE
author_facet Kazuhito Mietani
Masahiko Sumitani
Toru Ogata
Nobutake Shimojo
Reo Inoue
Hiroaki Abe
Gaku Kawamura
Yoshitsugu Yamada
author_sort Kazuhito Mietani
title Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
title_short Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
title_full Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
title_fullStr Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
title_full_unstemmed Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
title_sort dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2019-01-01
description BACKGROUND:Delirium is the most common postoperative complication of the central nervous system (CNS) that can trigger long-term cognitive impairment. Its underlying mechanism is not fully understood, but the dysfunction of the blood-brain barrier (BBB) has been implicated. The serum levels of the axonal damage biomarker, phosphorylated neurofilament heavy subunit (pNF-H) increase in moderate to severe delirium patients, indicating that postoperative delirium can induce irreversible CNS damage. Here, we investigated the relationship among postoperative delirium, CNS damage and BBB dysfunction, using pNF-H as reference. METHODS:Blood samples were collected from 117 patients within 3 postoperative days. These patients were clinically diagnosed with postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit. We measured intercellular adhesion molecule-1, platelet and endothelial cell adhesion molecule-1, vascular cell adhesion molecule-1, E-selectin, and P-selectin as biomarkers for BBB disruption, pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6), and pNF-H. We conducted logistic regression analysis including all participants to identify independent biomarkers contributing to serum pNF-H detection. Next, by multiple regression analysis with a stepwise method we sought to determine which biomarkers influence serum pNF-H levels, in pNF-H positive patients. RESULTS:Of the 117 subjects, 41 were clinically diagnosed with postoperative delirium, and 30 were positive for serum pNF-H. Sensitivity and specificity of serum pNF-H detection in the patients with postoperative delirium were 56% and 90%, respectively. P-selectin was the only independent variable to associate with pNF-H detection (P < 0.0001) in all 117 patients. In pNF-H positive patients, only PECAM-1 was associated with serum pNF-H levels (P = 0.02). CONCLUSIONS:Serum pNF-H could be an objective delirium biomarker, superior to conventional tools in clinical settings. In reference to pNF-H, P-selectin may be involved in the development of delirium-related CNS damage and PECAM-1 may contribute to the progression of delirium- related CNS damage.
url https://doi.org/10.1371/journal.pone.0222721
work_keys_str_mv AT kazuhitomietani dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT masahikosumitani dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT toruogata dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT nobutakeshimojo dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT reoinoue dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT hiroakiabe dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT gakukawamura dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
AT yoshitsuguyamada dysfunctionofthebloodbrainbarrierinpostoperativedeliriumpatientsreferringtotheaxonaldamagebiomarkerphosphorylatedneurofilamentheavysubunit
_version_ 1714818659173531648